Organization
Center for Translational Cancer Research
1 abstract
Abstract
Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, National Institute of Animal Biotechnology, Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University,